Pharmaceutical Business review -

Pharmaceutical Business review -

Pharmaceutical Business review is using cookies

Continue Learn More

Close

May 9, 2024

IMA Life to build new pharma freeze-drying equipment production site

IMA Life North America is set to establish a new $30m facility in Tonawanda, New York, US, aimed at increasing its production capabilities for pharmaceutical freeze-drying equipment.

Artist’s rendering of IMA Life North America’s new $30m production facility in Tonawanda, New York. Credit: Governor Kathy Hochul/Empire State Development/IMA Life North America.

May 8, 2024

ImmunoACT and Caring Cross sign TriCAR-T cell therapy development deal

The companies will partner to develop and commercialise TriCAR-T cell immunotherapy targeting leukaemia and lymphoma. Credit: National Cancer Institute on Unsplash.

May 7, 2024

OverT Bio secures $16m in seed funding for cell therapy development

The investment will support OverT Bio's efforts to develop potentially curative treatments for advanced solid tumours. Credit: Colin Behrens from Pixabay.

Contracts

December 14, 2022

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Micrograph of psoriasis vulgaris. Credit: Jenny Giang, Marc A. J. Seelen, Martijn B. A. van Doorn, Robert Rissmann,Errol P. Prens and Jeffrey Damman/ commons.wikimedia.org.

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Neurology

Harbour BioMed, Moderna partner on immunotherapies development

Research & Development

Kite, Refuge sign license deal for gene expression platform for blood cancers

Oncology

Deals

Deals April 18, 2024

Biocon signs licensing and supply deal for diabetes drug in Brazil

Pharmaceutical Business Review

Q32 Bio concludes merger deal with Homology Medicines

Zuellig Pharma acquires Cialis and Alimta brands from Lilly

Oncology

Kindeva Drug Delivery acquires Summit Biosciences

Popular

PRESS RELEASES

Gerresheimer Performance Levels Simplify Choice of Optimum Solution

Sofgen Pharmaceuticals to Exhibit at CPhI North America 2024

Molnar Institute at Analytica 2024 – 9-12 April in Munich, Germany

Gerresheimer Decisively Continues on Profitable Growth Course in Financial Year 2023

Butterworth at Making Pharmaceuticals 2024 – 23-24 April in Coventry, UK

Suppliers

Whitepapers

Wound Care – Selecting the Right Antiseptic for Your Formulation

Topicals – Selecting the Right Antiseptic for Your Formulation

Oral Formulations – Selecting the Right Antiseptic for Your Formulation